Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
Conference Program for 2022 the World Conference on Lung Cancer
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2137
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
EP02.04 - Early Stage Non-small Cell Lung Cancer - Systemic Therapy
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Early Stage Non-small Cell Lung Cancer - Systemic Therapy
-
+
EP02.04-005 - Phase II NAUTIKA1 Study of Targeted Therapies in Stage II-III NSCLC: Preliminary Data of Neoadjuvant Alectinib for ALK+ NSCLC
Presenter: JAY M LEE | Author(s): Boris Sepesi, Eric Miguel Toloza, Jules Lin, Harvey Pass, Bruce Johnson, John Heymach, Melissa L Johnson, Beiying Ding, Katja Schulze, Qian Zhu, Celina Ngiam, Evelise Brandão, Ilze Bara, Jamie E Chaft- Abstract
Loading... -
+
EP02.04-007 - Phase 2 Trial of Neoadjuvant KRASG12C Directed Therapy with Adagrasib (MRTX849) With or Without Nivolumab in Resectable NSCLC (Neo-KAN)
Presenter: Patrick M Forde | Author(s): Susan C Scott, Chen Hu, Kellie Smith, Valsamo Anagnostou, JAY M LEE, Jonathan David Spicer, Peter B Illei, Elisabeth Prophet, Samuel Rosner, David S Ettinger, Josephine Feliciano, Christine Hann, Vincent Lam, Ben Levy, Joseph Murray, Julie Brahmer, Kristen A Marrone- Abstract
Loading...
-
+
OA14 - New Techniques to Improve Outcome in Early Stage NSCLC Patients Treated with Surgery or Radiotherapy
- 12:00 - 13:00
- 8/09/2022
- Location: Hall C8
- Not for CME Credit
- Type: Oral
- Track: Early Stage Non-small Cell Lung Cancer
- Moderators:Paul Van Schil, Fabio Moraes
-
+
OA14.06 - T-Cell Dynamics in Response to Neoadjuvant Atezolizumab in Early NSCLC by Antigen Response and T-Cell Receptor Sequencing
12:22 - 12:32 | Presenter: Filiz Oezkan | Author(s): Stephanie Hilz, Jessica Grindheim, Andrew Wallace, Michal Seweryn, Alexandre Reuben, JianJun Zhang, Dwight H Owen, Alan Nicholas, Mahesh Yadav, Deepti Nagakar, Patricia de Almeida, Peter Ebert, Edward Osborne, Ann Johnson, JAY M LEE, Paul Bunn, Bruce Johnson, Jamie E Chaft, Mark G. Kris, Valerie Williams Rusch, Katja Schulze, David J. Kwiatkowski, Ignacio Wistuba, David Carbone
- Abstract
Loading...
